Conference
Mature results of a randomized phase II study of OGX-011 in combination with docetaxel/prednisone versus docetaxel/prednisone in patients with metastatic castration-resistant prostate cancer
Abstract
5012
Authors
Chi KN; Hotte SJ; Yu E; Tu D; Eigl B; Tannock I; Saad F; North S; Powers J; Eisenhauer E
Volume
27
Pagination
pp. 5012-5012
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.5012
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X